Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Volitionrx Ltd

VNRX
Current price
0.76 USD +0.033 USD (+4.44%)
Last closed 0.75 USD
ISIN US9286611077
Sector Healthcare
Industry Diagnostics & Research
Exchange NYSE
Capitalization 65 456 536 USD
Yield for 12 month -1.15 %
1Y
3Y
5Y
10Y
15Y
VNRX
21.11.2021 - 28.11.2021

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada. Address: 1489 West Warm Springs Road, Henderson, NV, United States, 89014

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.27 USD

P/E ratio

Dividend Yield

Current Year

+775 302 USD

Last Year

+306 392 USD

Current Quarter

+395 797 USD

Last Quarter

+171 535 USD

Current Year

-636 325 USD

Last Year

-882 029 USD

Current Quarter

+72 000 USD

Last Quarter

-150 538 USD

Key Figures VNRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -31 643 828 USD
Operating Margin TTM -1766.16 %
PE Ratio
Return On Assets TTM -100.82 %
PEG Ratio
Return On Equity TTM -730.06 %
Wall Street Target Price 3.27 USD
Revenue TTM 976 516 USD
Book Value -0.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 83 %
Dividend Yield
Gross Profit TTM 306 392 USD
Earnings per share -0.4 USD
Diluted Eps TTM -0.4 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics VNRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History VNRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation VNRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 65.2861
Price Sales TTM 67.0307
Enterprise Value EBITDA -1.4312
Price Book MRQ 38.4366

Financials VNRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators VNRX

For 52 weeks

0.43 USD 1.23 USD
50 Day MA 0.68 USD
Shares Short Prior Month 399 091
200 Day MA 0.75 USD
Short Ratio 3.33
Shares Short 404 776
Short Percent 0.56 %